Anúncio
Anúncio

OSCR

OSCR logo

Oscar Health, Inc.

16.50
USD
Patrocinado
-0.02
-0.15%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

16.52

+0.03
+0.18%

Relatórios de Lucros OSCR

Rácio de surpresa positiva

OSCR separação 10 de 19 últimas estimativas.

53%

Próximo Relatório

Data do Próximo Relatório
05 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.19B
/
-$0.90
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+6.71%
/
+69.81%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+33.19%
/
+45.16%

Oscar Health, Inc. earnings per share and revenue

On 06 de nov. de 2025, OSCR reported earnings of -0.53 USD per share (EPS) for Q3 25, beating the estimate of -0.56 USD, resulting in a 6.64% surprise. Revenue reached 2.99 bilhão, compared to an expected 3.14 bilhão, with a -5.02% difference. The market reacted with a -2.76% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of -0.90 USD, with revenue projected to reach 3.19 bilhão USD, implying an aumentar of 69.81% EPS, and aumentar of 6.71% in Revenue from the last quarter.
FAQ
For Q3 2025, Oscar Health, Inc. reported EPS of -$0.53, beating estimates by 6.64%, and revenue of $2.99B, -5.02% below expectations.
The stock price moved down -2.76%, changed from $17.03 before the earnings release to $16.56 the day after.
The next earning report is scheduled for 05 de fev. de 2026.
Based on 13 analistas, Oscar Health, Inc. is expected to report EPS of -$0.90 and revenue of $3.19B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio